ArticleNature communications2026
Pathway-priming of intermediate phases in FACs-based wide-bandgap perovskites for Si tandem solar cells.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Wide-bandgap (WBG) perovskite solar cells (PSCs) have emerged as promising candidates for tandem applications, despite potential instability induced by halogen components. Formamidinium-cesium (FACs)-based perovskites represent as an intrinsically stable WBG system due to their low bromine-to-lead ratio and the absence of thermally unstable methylammonium. However, the performance of FACs-based WBG perovskites is highly dependent on achieving precise control over the formation dynamics. Here, we employ in-situ characterization to reveal that the key to this control lies in the evolution of the intermediate phase and propose a pathway-priming strategy. By strategically guiding the early formation of the CsPbX
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.